chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Dialysis, Dyspnoea, Intensive care
Clinical narrative: Presented to the ER 10/9 with c/o SOB; admitted 10/9 for acute hypoxic resp failure & PNA d/t COVID & tx w/steroids, zinc, Vit C, & pepcid; 10/10 added Zithromax; 10/11 added Cefipime; 10/12 tx to ICU d/t increased resp demand & increased WOB on Max AirVo settings.  Pt also developed AKI and was started on dialysis; 10/23 pt coded and ROSC unable to be achieved & pt expired.
Age: 65.0
Sex: M
Vaccine: VARZOS
Symptoms: Incorrect dose administered, Needle issue
Clinical narrative: When technician was administering the dose needle retracted prematurely outside of the arm and patient did not receive the whole dose. contacted gsk/shingrix manufacturer and anything less than <0.45ml is and invalid dose and CDC recommends revaccination with an underrage the same day.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19 pneumonia, Dyspnoea
Clinical narrative: Pesented to ED w/ c/o SOB; admitted 10/15 for acute hypoxic resp failure d/t COVID PNA; 10/15 - tx w/ Decadron, remdesivir, Vit C, azithromycin, Ceftriaxone, zinc, Vit C; pt on supplemental O2 during stay but weaned to RA on discharge.
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Rhabdomyolysis, SARS-CoV-2 test positive
Clinical narrative: Received Pfizer COVID vaccines on 3/5/2021 and 3/26/2021 Hospitalized on 9/23/2021 with positive COVID 19 and Rhabdomyolitis Booster Pfizer vaccine received on 1/8/2022
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Wanted a Moderna  COVID-19 vaccine Booster but was given a Pfizer COVID-19 vaccine as a booster instead.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Dyspnoea, Intensive care, Pneumonia aspiration
Clinical narrative: Presented with SOB, + Covid 9/22; Admit 9/24 to ICU with Covid PNA room air; tx with 9/24 Maxipime, steroids, singulair, zinc started 9/26 Remdesivir , Zosyn started; O2 requirements:  admitted on room air; 9/26 4 LPM 9/27 Airvo 50L/80% ? Aspiration PNA as well; 9/28 O2 requirements increasing; DNR 10/4 Hospice care initiated 10/5 D/C home hospice
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Presented with SOB, + Covid 9/22; Admit 9/24 to ICU with Covid PNA room air; tx with 9/24 Maxipime, steroids, singulair, zinc started 9/26 Remdesivir , Zosyn started; O2 requirements:  admitted on room air; 9/26 4 LPM 9/27 Airvo 50L/80% ? Aspiration PNA as well; 9/28 O2 requirements increasing; DNR 10/4 Hospice care initiated 10/5 D/C home hospice
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: no adverse effect patient received a miss-handled vaccine that was stored out of temperature range
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Chest pain, Pneumonia viral, SARS-CoV-2 test positive
Clinical narrative: Pfizer COVID vaccines received on 2/26/2021, 3/19/2021, and 9/29/2021 Hospitalized on 10/5/2021 with positive COVID 19, viral pneumonia, and chest pain
Age: 82.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Herpes zoster, Pruritus, Swelling, Swelling face
Clinical narrative: She got her vaccine on Thursday afternoon, noticed redness on her left forehead and around her eye.  When she got up Sunday morning her eyelid was swollen, partially closed, swelling on the area that had been red on her forehead and around her face.  She went to UC and then they sent her to the ER.  In the ER she got Prednisone and another pill to last 7 days.  In the meantime she has gone to Dr.  and that she had shingles.  She does still have shingles reaction with the itching and some swelling, but it keeps getting better.
Age: 82.0
Sex: F
Vaccine: VARZOS
Symptoms: Swelling of eyelid
Clinical narrative: She got her vaccine on Thursday afternoon, noticed redness on her left forehead and around her eye.  When she got up Sunday morning her eyelid was swollen, partially closed, swelling on the area that had been red on her forehead and around her face.  She went to UC and then they sent her to the ER.  In the ER she got Prednisone and another pill to last 7 days.  In the meantime she has gone to Dr.  and that she had shingles.  She does still have shingles reaction with the itching and some swelling, but it keeps getting better.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Injection site rash, Injection site urticaria
Clinical narrative: My upper arm, at the injection sight, started getting itchy, then a rash appeared, which turned into one big hive at the injection site.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, COVID-19, Chest pain, Productive cough, Respiratory tract congestion
Clinical narrative: Presented with CP, productive cough, congestion; + covid ED; Admit OBS 9/24 Tele; inpatient admit 9/25 tele; tx with 9/24   lovenox, singulair, zinc started; O2 requirements:  room air
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Presented with CP, productive cough, congestion; + covid ED; Admit OBS 9/24 Tele; inpatient admit 9/25 tele; tx with 9/24   lovenox, singulair, zinc started; O2 requirements:  room air
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Anti-cyclic citrullinated peptide antibody negative, Antibody test positive, Antinuclear antibody negative, Arthralgia, Borrelia test negative
Clinical narrative: 17 y.o. female here to visit University with minimal past medical history who presented to the emergency department for evaluation of hip, neck, elbow, and knee pain that started 7 days prior to admission.  She had been experiencing muscle pain in hips, neck, and knees.  She had diarrhea 1 week prior to her trip on 12/23/2021. Patient also reported nausea and a loss of appetite, but denied dysuria, abnormal vaginal bleeding, vaginal discharge, rashes. Patient also denied being around people who are sick. Denied alcohol use, illicit drug use.  She is vaccinated for COVID-19, and recently received her booster of Pfizer approximately 7 days prior to admission.  She and her mother notes symptoms started approximately 1 day after her vaccine.  She denied any history of nicotine use, drug use, alcohol use, sexual activity.  She has had a few rapid COVID tests over the last few days that are been negative. While in the hospital, she reported migratory joint pain, sore throat, hemoptysis and bilateral subconjunctival hemorrhage: Patient had covid booster on Jan 11, and later started having neck stiffness and headache, followed by migratory joint pain (L knee -> hips -> R knee -> L elbow -> L knee) and fever and chills on Jan 16th. Hemoptysis 1 episode (1/20). Nasal bleed 2 episodes (1/21). All the positive results including C.diff, E.coli, Shigella and Salmonella may explain fever, headache and diarrhea but none of them could explain her symptoms of migratory polyarthritis, hemoptysis, nasal bleeding and subconjunctival hemorrhage.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Chlamydia test negative, Clostridium test positive, Conjunctival haemorrhage, Decreased appetite
Clinical narrative: 17 y.o. female here to visit University with minimal past medical history who presented to the emergency department for evaluation of hip, neck, elbow, and knee pain that started 7 days prior to admission.  She had been experiencing muscle pain in hips, neck, and knees.  She had diarrhea 1 week prior to her trip on 12/23/2021. Patient also reported nausea and a loss of appetite, but denied dysuria, abnormal vaginal bleeding, vaginal discharge, rashes. Patient also denied being around people who are sick. Denied alcohol use, illicit drug use.  She is vaccinated for COVID-19, and recently received her booster of Pfizer approximately 7 days prior to admission.  She and her mother notes symptoms started approximately 1 day after her vaccine.  She denied any history of nicotine use, drug use, alcohol use, sexual activity.  She has had a few rapid COVID tests over the last few days that are been negative. While in the hospital, she reported migratory joint pain, sore throat, hemoptysis and bilateral subconjunctival hemorrhage: Patient had covid booster on Jan 11, and later started having neck stiffness and headache, followed by migratory joint pain (L knee -> hips -> R knee -> L elbow -> L knee) and fever and chills on Jan 16th. Hemoptysis 1 episode (1/20). Nasal bleed 2 episodes (1/21). All the positive results including C.diff, E.coli, Shigella and Salmonella may explain fever, headache and diarrhea but none of them could explain her symptoms of migratory polyarthritis, hemoptysis, nasal bleeding and subconjunctival hemorrhage.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Dengue virus test negative, Dengue virus test positive, Diarrhoea, Epistaxis, Escherichia test positive
Clinical narrative: 17 y.o. female here to visit University with minimal past medical history who presented to the emergency department for evaluation of hip, neck, elbow, and knee pain that started 7 days prior to admission.  She had been experiencing muscle pain in hips, neck, and knees.  She had diarrhea 1 week prior to her trip on 12/23/2021. Patient also reported nausea and a loss of appetite, but denied dysuria, abnormal vaginal bleeding, vaginal discharge, rashes. Patient also denied being around people who are sick. Denied alcohol use, illicit drug use.  She is vaccinated for COVID-19, and recently received her booster of Pfizer approximately 7 days prior to admission.  She and her mother notes symptoms started approximately 1 day after her vaccine.  She denied any history of nicotine use, drug use, alcohol use, sexual activity.  She has had a few rapid COVID tests over the last few days that are been negative. While in the hospital, she reported migratory joint pain, sore throat, hemoptysis and bilateral subconjunctival hemorrhage: Patient had covid booster on Jan 11, and later started having neck stiffness and headache, followed by migratory joint pain (L knee -> hips -> R knee -> L elbow -> L knee) and fever and chills on Jan 16th. Hemoptysis 1 episode (1/20). Nasal bleed 2 episodes (1/21). All the positive results including C.diff, E.coli, Shigella and Salmonella may explain fever, headache and diarrhea but none of them could explain her symptoms of migratory polyarthritis, hemoptysis, nasal bleeding and subconjunctival hemorrhage.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Haemoptysis, Headache, Hepatitis viral test negative, Immunology test, Malaria antibody test negative
Clinical narrative: 17 y.o. female here to visit University with minimal past medical history who presented to the emergency department for evaluation of hip, neck, elbow, and knee pain that started 7 days prior to admission.  She had been experiencing muscle pain in hips, neck, and knees.  She had diarrhea 1 week prior to her trip on 12/23/2021. Patient also reported nausea and a loss of appetite, but denied dysuria, abnormal vaginal bleeding, vaginal discharge, rashes. Patient also denied being around people who are sick. Denied alcohol use, illicit drug use.  She is vaccinated for COVID-19, and recently received her booster of Pfizer approximately 7 days prior to admission.  She and her mother notes symptoms started approximately 1 day after her vaccine.  She denied any history of nicotine use, drug use, alcohol use, sexual activity.  She has had a few rapid COVID tests over the last few days that are been negative. While in the hospital, she reported migratory joint pain, sore throat, hemoptysis and bilateral subconjunctival hemorrhage: Patient had covid booster on Jan 11, and later started having neck stiffness and headache, followed by migratory joint pain (L knee -> hips -> R knee -> L elbow -> L knee) and fever and chills on Jan 16th. Hemoptysis 1 episode (1/20). Nasal bleed 2 episodes (1/21). All the positive results including C.diff, E.coli, Shigella and Salmonella may explain fever, headache and diarrhea but none of them could explain her symptoms of migratory polyarthritis, hemoptysis, nasal bleeding and subconjunctival hemorrhage.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Myalgia, Nausea, Neck pain, Oropharyngeal pain
Clinical narrative: 17 y.o. female here to visit University with minimal past medical history who presented to the emergency department for evaluation of hip, neck, elbow, and knee pain that started 7 days prior to admission.  She had been experiencing muscle pain in hips, neck, and knees.  She had diarrhea 1 week prior to her trip on 12/23/2021. Patient also reported nausea and a loss of appetite, but denied dysuria, abnormal vaginal bleeding, vaginal discharge, rashes. Patient also denied being around people who are sick. Denied alcohol use, illicit drug use.  She is vaccinated for COVID-19, and recently received her booster of Pfizer approximately 7 days prior to admission.  She and her mother notes symptoms started approximately 1 day after her vaccine.  She denied any history of nicotine use, drug use, alcohol use, sexual activity.  She has had a few rapid COVID tests over the last few days that are been negative. While in the hospital, she reported migratory joint pain, sore throat, hemoptysis and bilateral subconjunctival hemorrhage: Patient had covid booster on Jan 11, and later started having neck stiffness and headache, followed by migratory joint pain (L knee -> hips -> R knee -> L elbow -> L knee) and fever and chills on Jan 16th. Hemoptysis 1 episode (1/20). Nasal bleed 2 episodes (1/21). All the positive results including C.diff, E.coli, Shigella and Salmonella may explain fever, headache and diarrhea but none of them could explain her symptoms of migratory polyarthritis, hemoptysis, nasal bleeding and subconjunctival hemorrhage.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Polyarthritis, Pyrexia, Respiratory viral panel, Rheumatoid factor negative, SARS-CoV-2 test negative
Clinical narrative: 17 y.o. female here to visit University with minimal past medical history who presented to the emergency department for evaluation of hip, neck, elbow, and knee pain that started 7 days prior to admission.  She had been experiencing muscle pain in hips, neck, and knees.  She had diarrhea 1 week prior to her trip on 12/23/2021. Patient also reported nausea and a loss of appetite, but denied dysuria, abnormal vaginal bleeding, vaginal discharge, rashes. Patient also denied being around people who are sick. Denied alcohol use, illicit drug use.  She is vaccinated for COVID-19, and recently received her booster of Pfizer approximately 7 days prior to admission.  She and her mother notes symptoms started approximately 1 day after her vaccine.  She denied any history of nicotine use, drug use, alcohol use, sexual activity.  She has had a few rapid COVID tests over the last few days that are been negative. While in the hospital, she reported migratory joint pain, sore throat, hemoptysis and bilateral subconjunctival hemorrhage: Patient had covid booster on Jan 11, and later started having neck stiffness and headache, followed by migratory joint pain (L knee -> hips -> R knee -> L elbow -> L knee) and fever and chills on Jan 16th. Hemoptysis 1 episode (1/20). Nasal bleed 2 episodes (1/21). All the positive results including C.diff, E.coli, Shigella and Salmonella may explain fever, headache and diarrhea but none of them could explain her symptoms of migratory polyarthritis, hemoptysis, nasal bleeding and subconjunctival hemorrhage.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Salmonella test positive, Shigella test positive, Streptococcus test negative, Treponema test negative, Typhus rickettsia test
Clinical narrative: 17 y.o. female here to visit University with minimal past medical history who presented to the emergency department for evaluation of hip, neck, elbow, and knee pain that started 7 days prior to admission.  She had been experiencing muscle pain in hips, neck, and knees.  She had diarrhea 1 week prior to her trip on 12/23/2021. Patient also reported nausea and a loss of appetite, but denied dysuria, abnormal vaginal bleeding, vaginal discharge, rashes. Patient also denied being around people who are sick. Denied alcohol use, illicit drug use.  She is vaccinated for COVID-19, and recently received her booster of Pfizer approximately 7 days prior to admission.  She and her mother notes symptoms started approximately 1 day after her vaccine.  She denied any history of nicotine use, drug use, alcohol use, sexual activity.  She has had a few rapid COVID tests over the last few days that are been negative. While in the hospital, she reported migratory joint pain, sore throat, hemoptysis and bilateral subconjunctival hemorrhage: Patient had covid booster on Jan 11, and later started having neck stiffness and headache, followed by migratory joint pain (L knee -> hips -> R knee -> L elbow -> L knee) and fever and chills on Jan 16th. Hemoptysis 1 episode (1/20). Nasal bleed 2 episodes (1/21). All the positive results including C.diff, E.coli, Shigella and Salmonella may explain fever, headache and diarrhea but none of them could explain her symptoms of migratory polyarthritis, hemoptysis, nasal bleeding and subconjunctival hemorrhage.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Pfizer was administered after the Beyond Use Date of 3/24/2022
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, Blood beta-D-glucan increased, COVID-19, Pneumocystis jirovecii pneumonia, Pneumonia
Clinical narrative: Symptoms started 9/28/2021 Admitted to Hospital on 10/1/2021 Diagnosis of Acute Hypoxic Respiratory Failure, pneumonia in immunocompromised host, COVID-19 virus, and  elevated Fungitell - suspected PJP pneumonia Treatment included: Remdesivir, Steroid, Cefepime, Zyvox, Meropenem, Bactrim, and Lasix
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, COVID-19, COVID-19 pneumonia, Chest discomfort, Chronic obstructive pulmonary disease
Clinical narrative: Presented with SOB/ chest tightness, hypoxic; Covid + ED; Admit 9/26 medical Covid PNA/COPD exacerbation, on 3 LPM O2; tx with 9/26 Maxipime, Rocephin, steroids, vanc, lovenox started  9/27 Zithromax, levaquin, singulair, zinc started; O2 initially at 3 LPM and down to 2 LPM (baseline) at time of d/c
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Hypoxia, SARS-CoV-2 test positive
Clinical narrative: Presented with SOB/ chest tightness, hypoxic; Covid + ED; Admit 9/26 medical Covid PNA/COPD exacerbation, on 3 LPM O2; tx with 9/26 Maxipime, Rocephin, steroids, vanc, lovenox started  9/27 Zithromax, levaquin, singulair, zinc started; O2 initially at 3 LPM and down to 2 LPM (baseline) at time of d/c
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Arteriosclerosis coronary artery, Autopsy, Death, Pain in extremity
Clinical narrative: reported symptoms of stomach and arm pain followed by death
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Illness, Migraine, Pain, Pyrexia
Clinical narrative: The night of receiving the vaccine I just got very ill with a fever and body aches and it triggered a migraine that lasted for several days.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Asthenia, COVID-19, COVID-19 pneumonia, Exposure to SARS-CoV-2
Clinical narrative: Presented with syncope, weakness, hypoxia; Covid dx 9/3 (exposed 8/29); went to ED previously and already received Remdesivir, PO steroids and monoclonal antibody treatment; Admit 9/14 to facility with Covid PNA; O2 requirements- started at 5 LPM and down to RA at time of D/C; tx with  high dose steroids, symbicort, lovenox, singulair, zinc
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia, Syncope
Clinical narrative: Presented with syncope, weakness, hypoxia; Covid dx 9/3 (exposed 8/29); went to ED previously and already received Remdesivir, PO steroids and monoclonal antibody treatment; Admit 9/14 to facility with Covid PNA; O2 requirements- started at 5 LPM and down to RA at time of D/C; tx with  high dose steroids, symbicort, lovenox, singulair, zinc
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Colour blindness, Corrective lens user, Fluorescence angiogram, Optic nerve injury, Visual acuity reduced
Clinical narrative: SUDDEN LOSS OF VISION ACUITY IN LEFT EYE.  LOSS OF ABILITY TO SEE COLOR IN PART OF LEFT EYE. UNABLE TO CORRECT VISION BY LENSES TO BETTER THAN 20/60 VISION.  TREATMENT BEING SOUGHT AT THIS TIME.
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Visual field tests
Clinical narrative: SUDDEN LOSS OF VISION ACUITY IN LEFT EYE.  LOSS OF ABILITY TO SEE COLOR IN PART OF LEFT EYE. UNABLE TO CORRECT VISION BY LENSES TO BETTER THAN 20/60 VISION.  TREATMENT BEING SOUGHT AT THIS TIME.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: no adverse effect patient received a miss-handled vaccine that was stored out of temperature range
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, Biliary catheter insertion, COVID-19, Cholecystitis, Condition aggravated
Clinical narrative: pt brought to ED with poor oral intake, pain with coughing  after recent cholecystitis with percutaneous biliary drain; pt had a positive COVID test 5 days earlier; still positive for COVID in ED; admitted to ICU; given decadron; respiratory status decreased; noninvasive ventilator for respiratory failure; DNR/DNI; pt worsened with an increased need for vasopressors; went into A Fib with RVR and passed away in the hospital
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Death, General physical health deterioration, Hypophagia, Intensive care
Clinical narrative: pt brought to ED with poor oral intake, pain with coughing  after recent cholecystitis with percutaneous biliary drain; pt had a positive COVID test 5 days earlier; still positive for COVID in ED; admitted to ICU; given decadron; respiratory status decreased; noninvasive ventilator for respiratory failure; DNR/DNI; pt worsened with an increased need for vasopressors; went into A Fib with RVR and passed away in the hospital
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Mechanical ventilation, Respiratory disorder, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: pt brought to ED with poor oral intake, pain with coughing  after recent cholecystitis with percutaneous biliary drain; pt had a positive COVID test 5 days earlier; still positive for COVID in ED; admitted to ICU; given decadron; respiratory status decreased; noninvasive ventilator for respiratory failure; DNR/DNI; pt worsened with an increased need for vasopressors; went into A Fib with RVR and passed away in the hospital
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse effect noted. Pt received expired vaccine.
Age: 95.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, COVID-19, Fall, Hypoxia, Inflammatory marker increased
Clinical narrative: Presented with GLF, noted to have hypoxia, elevated inflammatory markers; + covid with admit; Admit 9/25 to tele with hypoxia; tx: 9/25 maxipime, xarelto started   9/26 remdesivir, Vit D3, Vit B12, steroids, singulair, zinc started O2 requirements: 2 lpm throughout stay
Age: 95.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Presented with GLF, noted to have hypoxia, elevated inflammatory markers; + covid with admit; Admit 9/25 to tele with hypoxia; tx: 9/25 maxipime, xarelto started   9/26 remdesivir, Vit D3, Vit B12, steroids, singulair, zinc started O2 requirements: 2 lpm throughout stay
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: no adverse effect patient received a miss-handled vaccine that was stored out of temperature range
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: I contracted COVID 19 01/19/2022 with congestion, runny nose, and fatigue. Recovered after 5 days with only lingering fatigue for 3 weeks.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: no adverse effect patient received a miss-handled vaccine that was stored out of temperature range
Age: 53.0
Sex: F
Vaccine: VARZOS
Symptoms: Dizziness, Erythema
Clinical narrative: Facial redness, cheeks, forehea, and dizziness.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Atrial fibrillation, Cardiac failure acute, Cardiac failure congestive, Left ventricular failure
Clinical narrative: Patient presented to the ED and was subsequently hospitalized for Atrial fibrillation with RVR, Acute on chronic diastolic CHF within 6 weeks of receiving covid vaccination.
Age: 57.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Diarrhoea
Clinical narrative: Abdominal pain and diarrhea
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was given the Pfizer COVID-19 vaccine 8 days after the extended expiration date.  The patient did well during the waiting period after the vaccine.  Poison Control was called .  We planned to re-vaccinate per guidance from the Poison Control Center.   At this time the patient has declined re-vaccination.  He stated that he felt the vaccine would be sufficient .
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Condition aggravated, Pyrexia
Clinical narrative: Arthralgia. This is after the 1st booster shot (3rd shot). A day after the vaccination (less than 48 hrs), there is a pain in the joint of my right knee. The pain has persisted for the last 3 days. When I put weight on my right leg, there is a sharp pain in the knee joint.  The pain dissipates and dulls after taking long walk. My knees and joints have been health, experienced no physical injury or any kind of problem before. (This booster shoot was done where I have been visiting).
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Burning sensation, Cardiac disorder, Dizziness, Electrocardiogram
Clinical narrative: She got her vaccine, first started to feel the lethargy.  Later in the night her arm started to burn, has had some problems with paresthesia's.  Then that went away and then her heart started to race, felt strange in her own body, her head felt light headed and she felt nausea.  She called the UC and they told her to come in.  They did 2 EKG's and asked to do another one.  The 2nd one they asked if she had had a heart attack or a cardiac arrest and they wanted her to go to the ER.  Her parents came to get her, they did blood work, EKG's and a chest x-ray and they want her to get a FU with a cardiologist.  This lasted for about 4-5 hours and then went away.    She went to medical Center.    She did not have any reactions like this with the other vaccines, the last one just no energy.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram abnormal, Extra dose administered, Feeling abnormal, Lethargy, Nausea
Clinical narrative: She got her vaccine, first started to feel the lethargy.  Later in the night her arm started to burn, has had some problems with paresthesia's.  Then that went away and then her heart started to race, felt strange in her own body, her head felt light headed and she felt nausea.  She called the UC and they told her to come in.  They did 2 EKG's and asked to do another one.  The 2nd one they asked if she had had a heart attack or a cardiac arrest and they wanted her to go to the ER.  Her parents came to get her, they did blood work, EKG's and a chest x-ray and they want her to get a FU with a cardiologist.  This lasted for about 4-5 hours and then went away.    She went to medical Center.    She did not have any reactions like this with the other vaccines, the last one just no energy.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations, Paraesthesia, X-ray
Clinical narrative: She got her vaccine, first started to feel the lethargy.  Later in the night her arm started to burn, has had some problems with paresthesia's.  Then that went away and then her heart started to race, felt strange in her own body, her head felt light headed and she felt nausea.  She called the UC and they told her to come in.  They did 2 EKG's and asked to do another one.  The 2nd one they asked if she had had a heart attack or a cardiac arrest and they wanted her to go to the ER.  Her parents came to get her, they did blood work, EKG's and a chest x-ray and they want her to get a FU with a cardiologist.  This lasted for about 4-5 hours and then went away.    She went to medical Center.    She did not have any reactions like this with the other vaccines, the last one just no energy.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse effect noted. Pt received expired vaccine.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram pulmonary, COVID-19 pneumonia, Hyperglycaemia, Hypoxia
Clinical narrative: Pfizer COVID-19 vaccines received on 03/13/2021 and 04/03/2021. Hospitalized on 10/31/2021 Diagnosis: COVID-19 pneumonia, hypoxia and hyperglycemia. Treatment: CTA of chest, oxygen support, Remdesivir, dexamethasone, insulin sliding scale, metformin and glipizide.
Age: 1.5
Sex: M
Vaccine: HEPA
Symptoms: Pyrexia, Seizure
Clinical narrative: fever to 101 and seizure ( 18 minutes)
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Pain
Clinical narrative: Patient received 1st Moderna Booster on 12/29/2021. Patient received 2nd Moderna Booster on 4/6/2022, but was not eligible for 2nd Moderna booster until 04/29/2022. Patient had no immediate adverse reaction after administration of 2nd Moderna Booster. Patient was contacted on 4/7/2022 and denied any adverse reactions.  Patient reported that he had a "little less achiness than previous doses".
Age: 0.17
Sex: F
Vaccine: RV5
Symptoms: Immediate post-injection reaction, Incorrect route of product administration, Oedema peripheral
Clinical narrative: Patient ordered to receive vaccinations prior to discharge.  This consisted of Vaxelis (DTaP, IPV, Hib, Hep B), PCV 13, and Rotavirus.  Immediately following the administration of the medications, the RN came to notify me that she had unintentionally gave the Rotavirus IM instead of PO.  She stated that she drew up two 1ml syringes and administered those in her right thigh.  The RN went and notified the mother and grandmother.  The mother was distraught, yelling in the hallway that the RN should be fired.  Dr.  and I asked if we could speak to her in their private room.  Grandma was holding the patient.  Patient assessed. Patient well-perfused and stable.  Right thigh slightly edematous but soft with 2+ pedal pulses.  Patient hooked up back to monitor and vital signs stable.  Discussed with family the plan to involve pharmacy to look at any known risk factors.  Pharmacy found a CDC MMR from 2014 detailing similar experience.  The side effects reported included redness at insertion site and irritability.  We also notified and included our charge nurse, nursing manager and director.  The mom asked to speak with social work who quickly arrived at bedside.  I spoke with staff who had not seen a previous incident but asked us to follow for the following concerns symptoms; fever, erythema at the site, decreased perfusion including prolonged capillary refill, decreased palpable pulses and firmness at the site.  Pharmacy contacted Merck, the manufacturer of the product Rotateq, who did not have documentation of any similar cases but would email us with any further information.  Upon discharge from the unit, the VS remained stable with her right thigh much less edematous and good perfusion.  Grandmother is a family nurse practitioner and verbalized understanding of concerning symptoms to notify provider regarding patient.  Plan to contact family tonight and tomorrow to follow up on patient status.
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asymptomatic COVID-19, Hypertension, SARS-CoV-2 test positive, Small intestinal obstruction, Umbilical hernia
Clinical narrative: Moderna COVID vaccines received on 2/26/2021 and 3/26/2021 Hospitalized at Hospital on 10/31/2021 Diagnosis: Positive COVID 19 with rapid but repeat PCR test was negative, partial small bowel obstruction, Acute UTI, Hypertension, Umbilical Hernia Treatment related to bowel obstruction, removed COVID restrictions due to negative PCR test, rapid likely false positive since asymptomatic and vaccinated per report
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Urinary tract infection
Clinical narrative: Moderna COVID vaccines received on 2/26/2021 and 3/26/2021 Hospitalized at Hospital on 10/31/2021 Diagnosis: Positive COVID 19 with rapid but repeat PCR test was negative, partial small bowel obstruction, Acute UTI, Hypertension, Umbilical Hernia Treatment related to bowel obstruction, removed COVID restrictions due to negative PCR test, rapid likely false positive since asymptomatic and vaccinated per report
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Hip arthroplasty
Clinical narrative: Patient hospitalized Status post total replacement of left hip within 6 weeks of receiving covid vaccination.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Pfizer was administered after the BUD 03/24/2022
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute respiratory failure, Atrial fibrillation, COVID-19 pneumonia, Chronic obstructive pulmonary disease, Computerised tomogram
Clinical narrative: Moderna COVID vaccines received on 02/02/2021 and 03/02/2021 Hospitalized at Hospital on 10/23/2021 Diagnosis of Acute Respiratory Failure, Acute GI bleed, COPD, Atrial Fibrillation with rapid ventricular response, COVID 19 pneumonia, DM II in Obesity, Pulmonary nodule Treatment included: Supplemental Oxygen, CT scan, Labs, Decadron, ceftriaxone, azithromycin, hospitalization Moderna Booster received on 12/7/2021 after the adverse event of 10/23/2021
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Gastrointestinal haemorrhage, Laboratory test, Obesity, Pulmonary mass, Type 2 diabetes mellitus
Clinical narrative: Moderna COVID vaccines received on 02/02/2021 and 03/02/2021 Hospitalized at Hospital on 10/23/2021 Diagnosis of Acute Respiratory Failure, Acute GI bleed, COPD, Atrial Fibrillation with rapid ventricular response, COVID 19 pneumonia, DM II in Obesity, Pulmonary nodule Treatment included: Supplemental Oxygen, CT scan, Labs, Decadron, ceftriaxone, azithromycin, hospitalization Moderna Booster received on 12/7/2021 after the adverse event of 10/23/2021
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pyrexia, Tremor
Clinical narrative: Fever 104 F, severe body aches, severe chills/shaking, headache - started at 10pm and progressively worsened. Fever broke at 10 am on 1/26/21. Other symptoms resolved by 1/28/21
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Anaemia, Condition aggravated, Inflammatory marker increased, Neutropenia, Pyrexia
Clinical narrative: Fever, elevation in inflammatory markers, worsening of neutropenia and anemia requiring hospitalization for PRBC transfusion
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Red blood cell transfusion
Clinical narrative: Fever, elevation in inflammatory markers, worsening of neutropenia and anemia requiring hospitalization for PRBC transfusion
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Adverse event
Clinical narrative: Pfizer COVID vaccines received on 7/16/2021 and 8/6/2021 Hospitalization at local Hospital on 10/20/2021. No diagnosis or treatment information available at this time  Pfizer Booster received on 2/19/2022 which is after the adverse event of 10/20/2021
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Malaise, Pleuritic pain, Pulmonary pain
Clinical narrative: I contracted COVID on 03/11/2022, I really did not have a lot of symptoms, but I was having trouble like my lungs hurt. It was like pleurisy, and I had a bit of a cough. That started on a Friday and had a infusion on a Tuesday. After a week or so I started feeling well. It was about a week I felt. I had an actual infusion instead of the pills. I thought the infusion was interesting, there was many people going in and out. I noticed that no-one had many symptoms, but did have underlying conditions.
Age: 34.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Cardiac arrest, Epilepsy, Otitis media, Troponin increased
Clinical narrative: Pfizer COVID vaccines on 2/8/2021 and 3/1/2021 Hospitalized on 10/12/2021 at hospital Diagnosis of epileptic seizure, COVID 19, Cardiac arrest, elevated tropinin, and otitis media Treatment included, Augmentin, Topamax 50 mg twice daily, and cardiology consult Additional Pfizer booster received on 11/18/2021 after the adverse event on 10/12/2021
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Pfizer was administered after the BUD 3/24/2022
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, Blood glucose decreased, COVID-19, Cystitis, Inappropriate schedule of product administration
Clinical narrative: Pfizer COVID vaccines received on 3/24/2021 and 4/20/2021. Hospitalized at Hospital on 11/2/2021 discharged on 11/8/2021 Diagnosis of Unresponsive, Altered Mental State, initial blood sugar 40, acute respiratory failure with hypoxia, aspiration pneumonia of lower lobe (unspecified side), cystitis without hematuria first positive COVID was 10/12/2021 was patient at hospital discharged on 10/13/2021  extubated on 11/5/2021 and discharged to home with hospice
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Mental status changes, Pneumonia aspiration, SARS-CoV-2 test positive, Unresponsive to stimuli
Clinical narrative: Pfizer COVID vaccines received on 3/24/2021 and 4/20/2021. Hospitalized at Hospital on 11/2/2021 discharged on 11/8/2021 Diagnosis of Unresponsive, Altered Mental State, initial blood sugar 40, acute respiratory failure with hypoxia, aspiration pneumonia of lower lobe (unspecified side), cystitis without hematuria first positive COVID was 10/12/2021 was patient at hospital discharged on 10/13/2021  extubated on 11/5/2021 and discharged to home with hospice
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Vaccine approved for persons 18 and up. Patient was 17 at time of administration.
Age: 86.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Adverse event
Clinical narrative: Moderna COVID vaccines received on 1/29/2021 and 2/26/2021 Hospitalized at Hospital on 10/8/2021 for COVID-19 Additional Moderna Booster received on 12/30/2021 after the adverse event
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Angiogram pulmonary abnormal, Atypical pneumonia, COVID-19 pneumonia, Cardiomegaly
Clinical narrative: Recent admission for COVID pneumonia and left lower extremity DVT at Medical Center was brought into another medical center due to lethargy and concern for aspiration. Patient with severe dementia and is unable to provide any additional history.  Reports that she was admitted at the hospital for antibiotics and discharged with 3 days of cefdinir. She was diagnosed with COVID pneumonia. She was also found to have a left lower extremity DVT but not treated with any anticoagulation due to history of subdural hematoma which had to be drained in September of last year. After discharge patient was doing much belter and In her usual state of health. However, began to have more difficulty breathing and has been lethargic.  Pt was admitted at the hospital for further evaluation. Pt was noticed to have acute hypoxic respiratory failure likely secondary to COVID pneumonia vs. aspiration pneumonia. For the rest of her medical condition, home medication resumed. Pt's condition declined during the hospitalization. Pt was placed on IV steroids, breathing treatment, high amount of oxygen/ vapotherm. Palliative care was consulted. Per daughter who Is the POA, pt was placed on comfort care. Patient expired on January 16, 2022 at 2:15.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Death, Deep vein thrombosis, Dyspnoea, General physical health deterioration
Clinical narrative: Recent admission for COVID pneumonia and left lower extremity DVT at Medical Center was brought into another medical center due to lethargy and concern for aspiration. Patient with severe dementia and is unable to provide any additional history.  Reports that she was admitted at the hospital for antibiotics and discharged with 3 days of cefdinir. She was diagnosed with COVID pneumonia. She was also found to have a left lower extremity DVT but not treated with any anticoagulation due to history of subdural hematoma which had to be drained in September of last year. After discharge patient was doing much belter and In her usual state of health. However, began to have more difficulty breathing and has been lethargic.  Pt was admitted at the hospital for further evaluation. Pt was noticed to have acute hypoxic respiratory failure likely secondary to COVID pneumonia vs. aspiration pneumonia. For the rest of her medical condition, home medication resumed. Pt's condition declined during the hospitalization. Pt was placed on IV steroids, breathing treatment, high amount of oxygen/ vapotherm. Palliative care was consulted. Per daughter who Is the POA, pt was placed on comfort care. Patient expired on January 16, 2022 at 2:15.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Lethargy, Lung opacity, Pleural effusion, Pneumonia aspiration, Subdural haematoma evacuation
Clinical narrative: Recent admission for COVID pneumonia and left lower extremity DVT at Medical Center was brought into another medical center due to lethargy and concern for aspiration. Patient with severe dementia and is unable to provide any additional history.  Reports that she was admitted at the hospital for antibiotics and discharged with 3 days of cefdinir. She was diagnosed with COVID pneumonia. She was also found to have a left lower extremity DVT but not treated with any anticoagulation due to history of subdural hematoma which had to be drained in September of last year. After discharge patient was doing much belter and In her usual state of health. However, began to have more difficulty breathing and has been lethargic.  Pt was admitted at the hospital for further evaluation. Pt was noticed to have acute hypoxic respiratory failure likely secondary to COVID pneumonia vs. aspiration pneumonia. For the rest of her medical condition, home medication resumed. Pt's condition declined during the hospitalization. Pt was placed on IV steroids, breathing treatment, high amount of oxygen/ vapotherm. Palliative care was consulted. Per daughter who Is the POA, pt was placed on comfort care. Patient expired on January 16, 2022 at 2:15.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Death, General physical health deterioration, Hypotension, Mental status changes
Clinical narrative: 10/15/21 pt admitted to hospital with bacterial pneumonia; had a positive COVID test on 10/12/21 at SNF (name of facility not in medical records); given ABX; mentation improved; became hypotensive and ran fever; had UTI and aspiration pneumonia; pt's condition worsened and he was transitioned to comfort care and passed away in the hospital
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Pneumonia aspiration, Pneumonia bacterial, Pyrexia, SARS-CoV-2 test positive, Urinary tract infection
Clinical narrative: 10/15/21 pt admitted to hospital with bacterial pneumonia; had a positive COVID test on 10/12/21 at SNF (name of facility not in medical records); given ABX; mentation improved; became hypotensive and ran fever; had UTI and aspiration pneumonia; pt's condition worsened and he was transitioned to comfort care and passed away in the hospital
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse effect. Patient received expired vaccine.
Age: 56.0
Sex: M
Vaccine: PPV, UNK
Symptoms: Erythema, Skin warm, Tenderness
Clinical narrative: red, warm and tender to touch or use
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, COVID-19, COVID-19 pneumonia, Dyspnoea, Oropharyngeal pain
Clinical narrative: presented with SOB; fever, body aches, sore throat;  + Covid at home PTA; Admit 9/24 to tele with Covid PNA; tx with : 9/24 steroids, 9/25 vit C, Rocephin, Vit D3, doxycycline, lovenox, singulair, zinc O2 requirements: 2-4 LPM throughout; home on O2
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: presented with SOB; fever, body aches, sore throat;  + Covid at home PTA; Admit 9/24 to tele with Covid PNA; tx with : 9/24 steroids, 9/25 vit C, Rocephin, Vit D3, doxycycline, lovenox, singulair, zinc O2 requirements: 2-4 LPM throughout; home on O2
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: patient recevied 0.5ml instead of 0.25ml.  No adverse affects per patient.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Pfizer was administered after the BUD of 3/24/2022
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, COVID-19, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: Presented with SOB; + covid 9/8; Admit to OBS med 9/20; inpatient 9/21 withCovid infection, SpO2 95% at 2 LPM; tx with 9/20 steroids, lovenox, singulair, zinc ; O2 remained at 2 LPM throughout stay
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: no adverse effect patient received a miss-handled vaccine that was stored out of temperature range
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, COVID-19, COVID-19 pneumonia, Cough, Pyrexia
Clinical narrative: Presented with cough, congestion, fever x 2 days; covid + ED; Admit 9/17, inpatient 9/18 with Covid PNA; tx with 9/17 zithromax, maxipime,   9/18 rocephin, doxycycline,  9/19 Vit C, Vit D3, SQ heparin, zinc ; O2 requirements: RA initially; 9/18 5 LPM, 9/19 AirVo 50L/60% 9/21 back to 4 LPM then down to 2 LPM at d/c
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: Presented with cough, congestion, fever x 2 days; covid + ED; Admit 9/17, inpatient 9/18 with Covid PNA; tx with 9/17 zithromax, maxipime,   9/18 rocephin, doxycycline,  9/19 Vit C, Vit D3, SQ heparin, zinc ; O2 requirements: RA initially; 9/18 5 LPM, 9/19 AirVo 50L/60% 9/21 back to 4 LPM then down to 2 LPM at d/c
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dehydration, Dyspnoea, Pneumonia
Clinical narrative: Presented to the ED complaining of dehydration on 10/6/2021, c/o worsening cough and SOB, treated w/ supplemental O2 in ED & admitted for dehydration, COVID-19 & suspected PNA; 10/6 - tx w/Remdesivir, Ceftriaxone, dexamethasone & zinc. Patient was weaned off oxygen and she was discharged home on room air.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Anaemia, Autoimmune disorder, C-reactive protein increased, Cardiac discomfort, Chest pain
Clinical narrative: I went in the doctor with chest pain. I also have fatigue. It felt like I was a heart attack. They did an EKG. They did blood work, that my CPR marks were high. Then, I started having stomach problems in October. I was diagnosed in Small intestinal bacterial overgrowth. I am also anemia, I also have an auto immune disease. I have headache, nausea, and loss of weight. I am being referred to a cardiologist to make sure my heart is okay.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Gastrointestinal bacterial overgrowth, Gastrointestinal disorder, Headache, Nausea
Clinical narrative: I went in the doctor with chest pain. I also have fatigue. It felt like I was a heart attack. They did an EKG. They did blood work, that my CPR marks were high. Then, I started having stomach problems in October. I was diagnosed in Small intestinal bacterial overgrowth. I am also anemia, I also have an auto immune disease. I have headache, nausea, and loss of weight. I am being referred to a cardiologist to make sure my heart is okay.